HUP0800305A2 - Combinations containing an antifungal agent and astatine, and use of them - Google Patents
Combinations containing an antifungal agent and astatine, and use of themInfo
- Publication number
- HUP0800305A2 HUP0800305A2 HU0800305A HUP0800305A HUP0800305A2 HU P0800305 A2 HUP0800305 A2 HU P0800305A2 HU 0800305 A HU0800305 A HU 0800305A HU P0800305 A HUP0800305 A HU P0800305A HU P0800305 A2 HUP0800305 A2 HU P0800305A2
- Authority
- HU
- Hungary
- Prior art keywords
- astatine
- antifungal agent
- combinations containing
- combinations
- antifungal
- Prior art date
Links
- 229940121375 antifungal agent Drugs 0.000 title 1
- 239000003429 antifungal agent Substances 0.000 title 1
- 229910052789 astatine Inorganic materials 0.000 title 1
- RYXHOMYVWAEKHL-UHFFFAOYSA-N astatine atom Chemical compound [At] RYXHOMYVWAEKHL-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0800305A HUP0800305A2 (en) | 2008-05-09 | 2008-05-09 | Combinations containing an antifungal agent and astatine, and use of them |
PCT/HU2009/000043 WO2009136214A1 (en) | 2008-05-09 | 2009-05-07 | Combination compositions comprising antimycotic agents and statins and the use thereof |
EP09742410A EP2296644A1 (en) | 2008-05-09 | 2009-05-07 | Combination compositions comprising antimycotic agents and statins and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0800305A HUP0800305A2 (en) | 2008-05-09 | 2008-05-09 | Combinations containing an antifungal agent and astatine, and use of them |
Publications (2)
Publication Number | Publication Date |
---|---|
HU0800305D0 HU0800305D0 (en) | 2008-07-28 |
HUP0800305A2 true HUP0800305A2 (en) | 2010-10-28 |
Family
ID=89988273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0800305A HUP0800305A2 (en) | 2008-05-09 | 2008-05-09 | Combinations containing an antifungal agent and astatine, and use of them |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2296644A1 (hu) |
HU (1) | HUP0800305A2 (hu) |
WO (1) | WO2009136214A1 (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102911877B (zh) * | 2012-08-27 | 2013-11-13 | 浙江工业大学 | 一株海洋真菌分枝孢子菌属真菌球孢枝孢及其应用 |
WO2016144979A1 (en) | 2015-03-09 | 2016-09-15 | The Children's Mercy Hospital | Dermatophytosis prophylaxis and treatment |
CN107957477B (zh) * | 2017-12-20 | 2020-06-19 | 郑州泰丰制药有限公司 | 一种采用非水滴定法测定泊沙康唑含量的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4187141B2 (ja) * | 2002-04-12 | 2008-11-26 | 興和株式会社 | 新規なトロンボモジュリン発現促進剤 |
-
2008
- 2008-05-09 HU HU0800305A patent/HUP0800305A2/hu unknown
-
2009
- 2009-05-07 WO PCT/HU2009/000043 patent/WO2009136214A1/en active Application Filing
- 2009-05-07 EP EP09742410A patent/EP2296644A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2009136214A1 (en) | 2009-11-12 |
HU0800305D0 (en) | 2008-07-28 |
EP2296644A1 (en) | 2011-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181370T1 (hr) | Heterociklični spoj i njegova uporaba | |
HK1181789A1 (en) | Ntibody capable of binding specifically to -oligomer, nd use thereof | |
HK1194071A1 (en) | Certain triazolopyrazines, compositions thereof and methods of use therefor | |
AP2010005387A0 (en) | Use of defensins against tuberculosis. | |
PL2307391T3 (pl) | Tiadiazolilooksyfenyloamidyny i ich zastosowanie jako środki grzybobójcze | |
ZA201005761B (en) | Encapsulated benefit agent | |
GB0917044D0 (en) | Agents, uses and methods | |
EP2361915A4 (en) | NEW HETEROCYCLIC CONNECTION AND APPLICATION THEREOF | |
GB0917054D0 (en) | Agents, uses and methods | |
EP2237947A4 (en) | ADHESIVES WITH A DYE AND / OR AN ACTIVE SUBSTANCE | |
PL2307390T3 (pl) | Tiadiazolilooksyfenyloamidyny i ich zastosowanie jako środki grzybobójcze | |
EP2242854A4 (en) | COMPOUNDS AND USES THEREOF | |
EP2351732A4 (en) | NEW RAMALINE CONNECTION AND ITS USE | |
EP2380581A4 (en) | MUSCULAR DEVELOPMENT AGENT | |
IL212364A0 (en) | Neuropeptide-2-receptor (y-2r) agonists and uses thereof | |
EP2499282A4 (en) | GAMMA-SECRETASE MODULATION COMPOUNDS, METHODS FOR IDENTIFYING SAME, AND USES THEREOF | |
EP2322574A4 (en) | IONOMER RESIN, RESIN COMPOSITIONS CONTAINING THE SAME, AND USES THEREOF | |
HK1160925A1 (zh) | 組織蛋白酶 的用途 | |
EP2311472A4 (en) | AGENT FOR THE IMPROVEMENT OF COGNITIVE DISORDERS | |
EP2345660A4 (en) | ANTI-XDR-TB-MEDIUM, ANTI-MDR-TB-MEDIUM AND COMBINED ANTIBODY CLOUD | |
EP2399921A4 (en) | HETEROCYCLIC COMPOUND AND APPLICATIONS | |
EP2322608A4 (en) | TRANSFECTION AGENT | |
EP2305292A4 (en) | TRANSDERMAL IMMUNIZER OF S / O TYPE | |
HRP20160578T1 (hr) | Supstituirani furankarboksamidi i njihova upotreba | |
HU0800305D0 (en) | Combinations containing an antifungal agent and astatine, and use of them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |